Denali Therapeutics, Inc. (DNLI)
18.40
-0.55
(-2.90%)
USD |
NASDAQ |
Oct 13, 16:00
18.65
+0.25
(+1.36%)
After-Hours: 04:27
Denali Therapeutics Total Return Price : 18.40 for Oct. 13, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| October 13, 2026 | 18.40 |
| October 12, 2026 | 18.95 |
| October 09, 2026 | 19.45 |
| October 08, 2026 | 18.67 |
| October 07, 2026 | 19.16 |
| October 06, 2026 | 19.28 |
| October 05, 2026 | 19.91 |
| October 02, 2026 | 20.00 |
| October 01, 2026 | 20.53 |
| September 30, 2026 | 20.67 |
| September 29, 2026 | 20.81 |
| September 28, 2026 | 20.98 |
| September 25, 2026 | 20.39 |
| September 24, 2026 | 20.47 |
| September 23, 2026 | 20.46 |
| September 22, 2026 | 21.60 |
| September 21, 2026 | 20.47 |
| September 18, 2026 | 19.72 |
| September 17, 2026 | 20.13 |
| September 16, 2026 | 20.06 |
| September 15, 2026 | 20.38 |
| September 14, 2026 | 21.22 |
| September 11, 2026 | 21.09 |
| September 10, 2026 | 21.40 |
| September 09, 2026 | 21.57 |
| Date | Value |
|---|---|
| September 08, 2026 | 22.08 |
| September 04, 2026 | 22.28 |
| September 03, 2026 | 22.80 |
| September 02, 2026 | 22.85 |
| September 01, 2026 | 23.26 |
| August 31, 2026 | 23.76 |
| August 28, 2026 | 24.00 |
| August 27, 2026 | 24.67 |
| August 26, 2026 | 24.57 |
| August 25, 2026 | 24.93 |
| August 24, 2026 | 24.20 |
| August 21, 2026 | 24.92 |
| August 20, 2026 | 24.95 |
| August 19, 2026 | 25.69 |
| August 18, 2026 | 24.31 |
| August 17, 2026 | 24.35 |
| August 14, 2026 | 24.40 |
| August 13, 2026 | 24.82 |
| August 12, 2026 | 25.27 |
| August 11, 2026 | 24.69 |
| August 10, 2026 | 25.00 |
| August 07, 2026 | 24.83 |
| August 06, 2026 | 24.73 |
| August 05, 2026 | 24.42 |
| August 04, 2026 | 24.17 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 58.13 |
| Oncolytics Biotech, Inc. | 0.49 |
| Sangamo Therapeutics, Inc. | 0.1401 |
| Sarepta Therapeutics, Inc. | 16.51 |
| Anixa Biosciences, Inc. | 2.67 |